1. Home
  2. WETH vs MRKR Comparison

WETH vs MRKR Comparison

Compare WETH & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WETH

Wetouch Technology Inc.

HOLD

Current Price

$1.09

Market Cap

15.7M

Sector

N/A

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.09

Market Cap

18.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WETH
MRKR
Founded
1992
1999
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
18.7M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
WETH
MRKR
Price
$1.09
$1.09
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
134.8K
40.5K
Earning Date
04-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
15.38
33.61
EPS
0.32
N/A
Revenue
$45,136,818.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$936.27
P/E Ratio
$3.16
N/A
Revenue Growth
6.76
N/A
52 Week Low
$0.82
$0.81
52 Week High
$3.68
$2.46

Technical Indicators

Market Signals
Indicator
WETH
MRKR
Relative Strength Index (RSI) 43.99 35.81
Support Level $0.95 $1.05
Resistance Level $1.49 $1.54
Average True Range (ATR) 0.12 0.09
MACD -0.01 -0.00
Stochastic Oscillator 29.18 22.15

Price Performance

Historical Comparison
WETH
MRKR

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a business of research and development, manufacturing, and distribution of touchscreen displays to customers both in the PRC and overseas. The touchscreen products, which are manufactured by the Company, are mainly for use in financial terminals, automotive, Point of Sales, gaming, lottery, medical, Human-Machine Interface (HMI), and other specialized industries. The company sells touchscreen products both domestically in China and internationally, covering areas in Mainland China, including but not limited to the eastern, southern, northern, and southwest regions of Mainland China, Taiwan, South Korea, Germany, and other countries.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Share on Social Networks: